However, their cytotoxic function is often suppressed by tumor-induced immune checkpoints, such as programmed death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) (19–22). The gene discussed is CTLA4; the disease is neoplasm.